Clinical Trial Update: A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and preliminary efficacy of a recombinant vaccinia virus delivered transdermally within liver tumors in patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Pexa-Vec (JX-594) (recombinant vaccinia virus)

Snippet

Sponsor: Jennerex Biotherapeutics | Conditions: Neoplasms, Liver | Phase 1 | Status: COMPLETED